301 related articles for article (PubMed ID: 22387464)
1. Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers.
Bultmann S; Morbitzer R; Schmidt CS; Thanisch K; Spada F; Elsaesser J; Lahaye T; Leonhardt H
Nucleic Acids Res; 2012 Jul; 40(12):5368-77. PubMed ID: 22387464
[TBL] [Abstract][Full Text] [Related]
2. Differential recruitment of methyl CpG-binding domain factors and DNA methyltransferases by the orphan receptor germ cell nuclear factor initiates the repression and silencing of Oct4.
Gu P; Xu X; Le Menuet D; Chung AC; Cooney AJ
Stem Cells; 2011 Jul; 29(7):1041-51. PubMed ID: 21608077
[TBL] [Abstract][Full Text] [Related]
3. The last half-repeat of transcription activator-like effector (TALE) is dispensable and thereby TALE-based technology can be simplified.
Zheng CK; Wang CL; Zhang XP; Wang FJ; Qin TF; Zhao KJ
Mol Plant Pathol; 2014 Sep; 15(7):690-7. PubMed ID: 24521457
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
5. DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells.
Banerjee S; Bacanamwo M
Exp Cell Res; 2010 Jan; 316(2):172-80. PubMed ID: 19715692
[TBL] [Abstract][Full Text] [Related]
6. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
7. Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors.
Hu J; Lei Y; Wong WK; Liu S; Lee KC; He X; You W; Zhou R; Guo JT; Chen X; Peng X; Sun H; Huang H; Zhao H; Feng B
Nucleic Acids Res; 2014 Apr; 42(7):4375-90. PubMed ID: 24500196
[TBL] [Abstract][Full Text] [Related]
8. Dynamic epigenetic regulation of the Oct4 and Nanog regulatory regions during neural differentiation in rhesus nuclear transfer embryonic stem cells.
Wang K; Chen Y; Chang EA; Knott JG; Cibelli JB
Cloning Stem Cells; 2009 Dec; 11(4):483-96. PubMed ID: 20025521
[TBL] [Abstract][Full Text] [Related]
9. H3K4 Methyltransferase Set1a Is A Key Oct4 Coactivator Essential for Generation of Oct4 Positive Inner Cell Mass.
Fang L; Zhang J; Zhang H; Yang X; Jin X; Zhang L; Skalnik DG; Jin Y; Zhang Y; Huang X; Li J; Wong J
Stem Cells; 2016 Mar; 34(3):565-80. PubMed ID: 26785054
[TBL] [Abstract][Full Text] [Related]
10. Cited2 gene controls pluripotency and cardiomyocyte differentiation of murine embryonic stem cells through Oct4 gene.
Li Q; Ramírez-Bergeron DL; Dunwoodie SL; Yang YC
J Biol Chem; 2012 Aug; 287(34):29088-100. PubMed ID: 22761414
[TBL] [Abstract][Full Text] [Related]
11. Breaking through an epigenetic wall: re-activation of Oct4 by KRAB-containing designer zinc finger transcription factors.
Juárez-Moreno K; Erices R; Beltran AS; Stolzenburg S; Cuello-Fredes M; Owen GI; Qian H; Blancafort P
Epigenetics; 2013 Feb; 8(2):164-76. PubMed ID: 23314702
[TBL] [Abstract][Full Text] [Related]
12. Oct4 is epigenetically regulated by methylation in normal placenta and gestational trophoblastic disease.
Zhang HJ; Siu MK; Wong ES; Wong KY; Li AS; Chan KY; Ngan HY; Cheung AN
Placenta; 2008 Jun; 29(6):549-54. PubMed ID: 18440631
[TBL] [Abstract][Full Text] [Related]
13. Pluripotency transcription factor Oct4 mediates stepwise nucleosome demethylation and depletion.
Shakya A; Callister C; Goren A; Yosef N; Garg N; Khoddami V; Nix D; Regev A; Tantin D
Mol Cell Biol; 2015 Mar; 35(6):1014-25. PubMed ID: 25582194
[TBL] [Abstract][Full Text] [Related]
14. NonO binds to the CpG island of oct4 promoter and functions as a transcriptional activator of oct4 gene expression.
Park Y; Lee JM; Hwang MY; Son GH; Geum D
Mol Cells; 2013 Jan; 35(1):61-9. PubMed ID: 23212346
[TBL] [Abstract][Full Text] [Related]
15. Synergistic re-activation of epigenetically silenced genes by combinatorial inhibition of DNMTs and LSD1 in cancer cells.
Han H; Yang X; Pandiyan K; Liang G
PLoS One; 2013; 8(9):e75136. PubMed ID: 24040395
[TBL] [Abstract][Full Text] [Related]
16. Hierarchical Oct4 Binding in Concert with Primed Epigenetic Rearrangements during Somatic Cell Reprogramming.
Chen J; Chen X; Li M; Liu X; Gao Y; Kou X; Zhao Y; Zheng W; Zhang X; Huo Y; Chen C; Wu Y; Wang H; Jiang C; Gao S
Cell Rep; 2016 Feb; 14(6):1540-1554. PubMed ID: 26832419
[TBL] [Abstract][Full Text] [Related]
17. Protein arginine methyltransferase 7-mediated
Chen TY; Lee SH; Dhar SS; Lee MG
J Biol Chem; 2018 Mar; 293(11):3925-3936. PubMed ID: 29378844
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells.
Yang J; Chai L; Fowles TC; Alipio Z; Xu D; Fink LM; Ward DC; Ma Y
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19756-61. PubMed ID: 19060217
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome.
Balmer NV; Weng MK; Zimmer B; Ivanova VN; Chambers SM; Nikolaeva E; Jagtap S; Sachinidis A; Hescheler J; Waldmann T; Leist M
Hum Mol Genet; 2012 Sep; 21(18):4104-14. PubMed ID: 22723015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
